Best Hospitals for Ventricular Septal Defect (VSD) Repair in Dubai, UAE

In India, VSD Repair — including open surgical patch closure under cardiopulmonary bypass — is typically priced between USD 4,000 and USD 9,000 at JCI- and NABH-accredited hospitals. This range covers the surgical procedure, cardiopulmonary bypass consumables, 7–12 days of inpatient stay (including 2–4 days in the Pediatric Cardiac ICU), standard cardiac medications, and operating theater costs. Transcatheter device closure, which avoids open surgery and has a shorter hospital stay of 2–3 days, generally falls at the lower end of this range. In the UAE — specifically at DHA-licensed hospitals in Dubai and HAAD-licensed facilities in Abu Dhabi — the equivalent procedure is priced between USD 9,000 and USD 18,000, reflecting higher facility operating costs, premium nursing ratios, luxury inpatient environments, and the UAE's higher overall cost of healthcare delivery. Both destinations achieve equivalent clinical outcomes and internationally recognized safety standards. India is approximately 40–60% less expensive than the UAE for this procedure, making it the preferred destination for cost-sensitive international families, while the UAE is chosen by patients from the Gulf Cooperation Council (GCC), East Africa, and Europe who prioritize geographic proximity, luxury hospital environments, and Arabic-language clinical care. GAF Healthcare provides detailed itemized cost estimates tailored to your child's specific anatomy and planned procedure before any financial commitment is made.

The recommended minimum in-country stay before international long-haul flight clearance varies by the type of repair performed. Following open surgical repair (median sternotomy with patch closure under cardiopulmonary bypass), most pediatric cardiac surgery programs require a minimum of 4–6 weeks post-operatively before granting fit-to-fly certification. This duration allows for complete sternal healing (the sternum, which is divided during surgery, requires 4–6 weeks of bony union), resolution of any pleural or pericardial effusions that may develop in the post-operative period (post-pericardiotomy syndrome), confirmed stable cardiac rhythm on ECG, and documentation that the patient requires no supplemental oxygen. A formal fit-to-fly letter is issued by the treating cardiac surgeon only after an in-person outpatient review — typically at the 3-to-4-week post-discharge mark — including a clinical examination, wound assessment, ECG, and echocardiogram confirming patch integrity and no residual hemodynamic compromise. Following transcatheter device closure (catheter-based, no open surgery), the recovery is considerably faster: most patients can be cleared for international flight travel within 2–3 weeks of the procedure, provided there are no device-related complications and the follow-up echocardiogram shows satisfactory device position and endothelialization progress. GAF Healthcare arranges extended accommodation for the patient's attendants near the treating hospital throughout this entire recovery period and coordinates the outpatient review appointments to ensure the fit-to-fly milestone is met efficiently and safely.

VSD Repair is one of the highest-success-rate procedures in all of congenital cardiac surgery. At experienced, high-volume pediatric cardiac centers — including those in GAF Healthcare's partner network in India and the UAE — the overall procedural success rate exceeds 95–98%, defined as complete or hemodynamically insignificant residual defect closure with restoration of normal intracardiac pressure and flow dynamics. Operative mortality is below 1–2% for isolated VSD repair in non-neonatal patients at expert centers, and approaches 0.5% for elective cases in children beyond the neonatal period with no other significant comorbidities. For transcatheter device closure in anatomically suitable muscular VSDs, technical success rates (correct device deployment with ≤ trivial residual shunt at 6 months) exceed 95% in published multicenter series. The long-term outlook is excellent: the vast majority of patients who undergo timely VSD repair before irreversible pulmonary vascular disease develops achieve normal or near-normal right ventricular pressure, normal pulmonary artery pressure, and full physical activity without restriction by school age. Neurological and developmental outcomes are good, particularly in children repaired after the neonatal period; specialized neurodevelopmental follow-up programs at GAF's partner centers identify and support any children requiring early educational or therapeutic intervention. Adults who undergo repair of previously undetected VSDs also demonstrate significant improvement in functional capacity (NYHA class improvement by ≥ 1 grade) and halted progression of pulmonary hypertension in the majority of operable cases. Annual echocardiographic follow-up is recommended for a minimum of 5 years post-repair, transitioning to less frequent surveillance thereafter if hemodynamics remain normal.